Company intelligence / Profile preview

On Demand Therapeutics

Rockville, Maryland, United States

Ownership: Private
Employees: ~89
Development stage: Other

Overview

ODP has successfully validated its Pharmacy on Demand platform in pilot hospital programs (e.g., producing 12,000+ sterile syringes in Tupelo with zero failures), is expanding to nationwide network to supply at-risk medicines in real time, and has secured both public/private partnerships including HHS and DoD

Therapeutic areas: Other
Modalities: Small moleculeGeneric drugsCompounded medicinesDevice
Industry: Contract Manufacturing Organization

Partnerships

North Mississippi Health Services (pilot site)Azzur Group (Preferred Supplier)Wavelength Pharmaceuticals (BIRD Foundation Grant)Ginkgo Bioworks (ARPA-H project)

Beyond the preview

Go deeper on On Demand Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on On Demand Therapeutics.

Explore the full profile